Published in
SpringerOpen, Clinical and Translational Medicine, 10(11), 2021
DOI: 10.1002/ctm2.533
Links
Tools
The oral KIF11 inhibitor 4SC‐205 exhibits antitumor activity and potentiates standard and targeted therapies in primary and metastatic neuroblastoma models
Journal article published in 2021 by
Marc Masanas,
Nuria Masiá,
Leticia Suárez‐Cabrera,
Mireia Olivan,
Aroa Soriano 
,
Blanca Majem,
Laura Devis‐Jauregui,
Rebeca Burgos‐Panadero,
Carlos Jiménez,
Pau Rodriguez‐Sodupe,
Ariadna Boloix,
Ignasi Toledano,
Gabriela Guillén,
Alexandra Navarro,
David Llobet‐Navas
and other authors.
,
Blanca Majem,
Laura Devis‐Jauregui,
Rebeca Burgos‐Panadero,
Carlos Jiménez,
Pau Rodriguez‐Sodupe,
Ariadna Boloix,
Ignasi Toledano,
Gabriela Guillén,
Alexandra Navarro,
David Llobet‐Navas
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 